|
1
|
Moffat CJ, Pinder SE, Dixon AR, Elston CW,
Blamey RW and Ellis IO: Phyllodes tumours of the breast: a
clinicopathological review of thirty-two cases. Histopathology.
27:205–218. 1995. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Bernstein L, Deapen D and Ross RK: The
descriptive epidemiology of malignant cystosarcoma phyllodes tumors
of the breast. Cancer. 71:3020–3024. 1993. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Bartoli C, Zurrida SM and Clemente C:
Phyllodes tumor in a male patient with bilateral gynaecomastia
induced by oestrogen therapy for prostatic carcinoma. Eur J Surg
Oncol. 17:215–217. 1991.PubMed/NCBI
|
|
4
|
Keelan PA, Myers JL, Wold LE, Katzmann JA
and Gibney DJ: Phyllodes tumor: clinicopathologic review of 60
patients and flow cytometric analysis in 30 patients. Hum Pathol.
23:1048–1054. 1992. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Tan PH, Jayabaskar T, Chuah KL, et al:
Phyllodes tumors of the breast: the role of pathologic parameters.
Am J Clin Pathol. 123:529–540. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Rowell MD, Perry RR, Hsiu JG and Barranco
SC: Phyllodes tumors. Am J Surg. 165:376–379. 1993. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Reinfuss M, Mitus J, Duda K, Stelmach A,
Rys J and Smolak K: The treatment and prognosis of patients with
phyllodes tumor of the breast: an analysis of 170 cases. Cancer.
77:910–916. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Barth RJ Jr: Histologic features predict
local recurrence after breast conserving therapy of phyllodes
tumors. Breast Cancer Res Treat. 57:291–295. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Tan PH, Thike AA, Tan WJ, et al: Phyllodes
Tumour Network Singapore: Predicting clinical behaviour of breast
phyllodes tumours: a nomogram based on histological criteria and
surgical margins. J Clin Pathol. 65:69–76. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Abdalla HM and Sakr MA: Predictive factors
of local recurrence and survival following primary surgical
treatment of phyllodes tumors of the breast. J Egypt Natl Canc
Inst. 18:125–133. 2006.PubMed/NCBI
|
|
11
|
Chaney AW, Pollack A, McNeese MD, et al:
Primary treatment of cystosarcoma phyllodes of the breast. Cancer.
89:1502–1511. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Asoglu O, Ugurlu MM, Blanchard K, et al:
Risk factors for recurrence and death after primary surgical
treatment of malignant phyllodes tumors. Ann Surg Oncol.
11:1011–1017. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Macdonald OK, Lee CM, Tward JD, Chappel CD
and Gaffney DK: Malignant phyllodes tumor of the female breast:
association of primary therapy with cause-specific survival from
the Surveillance, Epidemiology, and End Results (SEER) program.
Cancer. 107:2127–2133. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Belkacémi Y, Bousquet G, Marsiglia H, et
al: Phyllodes tumor of the breast. Int J Radiat Oncol Biol Phys.
70:492–500. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Chen WH, Cheng SP, Tzen CY, et al:
Surgical treatment of phyllodes tumors of the breast: retrospective
review of 172 cases. J Surg Oncol. 91:185–194. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Mangi AA, Smith BL, Gadd MA, Tanabe KK,
Ott MJ and Souba WW: Surgical management of phyllodes tumors. Arch
Surg. 134:487–492. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Kapiris I, Nasiri N, A'Hern R, Healy V and
Gui GP: Outcome and predictive factors of local recurrence and
distant metastases following primary surgical treatment of
high-grade malignant phyllodes tumours of the breast. Eur J Surg
Oncol. 27:723–730. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Barrio AV, Clark BD, Goldberg JI, et al:
Clinicopathologic features and long-term outcomes of 293 phyllodes
tumors of the breast. Ann Surg Oncol. 14:2961–2970. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Guillot E, Couturaud B, Reyal F, et al:
Management of phyllodes breast tumors. Breast J. 17:129–137. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Barth RJ Jr, Wells WA, Mitchell SE and
Cole BF: A prospective, multi-institutional study of adjuvant
radiotherapy after resection of malignant phyllodes tumors. Ann
Surg Oncol. 16:2288–2294. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Ellis I, Sawyer EJ, Rampaul R and Pineda
CG: Phyllodes tumor of the breastTextbook of Uncommon Cancer.
Raghavan D, Brecher ML, Johnson DH, MerOpol NJ, Moots PL and Rose
PG: 3rd. Wiley; Chichester: pp. 209–217. 2006, View Article : Google Scholar
|
|
22
|
Pezner RD, Schultheiss TE and Paz IB:
Malignant phyllodes tumor of the breast: local control rates with
surgery alone. Int J Radiat Oncol Biol Phys. 71:710–713. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Parker SJ and Harries SA: Phyllodes
tumours. Postgrad Med J. 77:428–435. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Barth R J Jr: Margin negative, breast
conserving resection: adequate for benign phyllodes tumors, but
inadequate therapy for borderline and malignant phyllodes tumors.
Breast Cancer Res Treat. 142:463–464. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Gnerlich JL, Williams RT, Yao K, Jaskowiak
N and Kulkarni SA: Utilization of radiotherapy for malignant
phyllodes tumors: analysis of the National Cancer Data Base,
1998–2009. Ann Surg Oncol. 21:1222–1230. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Carlson RW, Allred DC, Anderson BO, et al:
Metastatic breast cancer, version 1.2012: featured updates to the
NCCN guidelines. J Natl Compr Canc Netw. 10:821–829.
2012.PubMed/NCBI
|
|
27
|
Higgins JP and Thompson SG: Quantifying
heterogeneity in a meta-analysis. Stat Med. 21:1539–1558. 2002.
View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Atkins D, Best D, Briss PA, et al: Grade
Working Group: Grading quality of evidence and strength of
recommendations. BMJ. 328:14902004. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Jaeschke R, Guyatt GH, Dellinger P, et al:
Use of grade grid to reach decisions on clinical practice
guidelines when consensus is elusive. BMJ. 337:a7442008.(In
French). View
Article : Google Scholar : PubMed/NCBI
|
|
30
|
Haberer S, Laé M, Seegers V, et al:
Management of malignant phyllodes tumors of the breast: the
experience of the Institut Curie. Cancer Radiother. 13:305–312.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Soumarová R, Seneklová Z, Horová H, et al:
Retrospective analysis of 25 women with malignant cystosarcoma
phyllodes - treatment results. Arch Gynecol Obstet. 269:278–281.
2004. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Pandey M, Mathew A, Kattoor J, et al:
Malignant phyllodes tumor. Breast J. 7:411–416. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Kim S, Kim JY, do H Kim, Jung WH and Koo
JS: Analysis of phyllodes tumor recurrence according to the
histologic grade. Breast Cancer Res Treat. 141:353–363. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Badar F, Mahmood S, Syed AA and Siddiqui
N: Malignant phyllodes tumour of the breast. J Ayub Med Coll
Abbottabad. 24:47–49. 2012.PubMed/NCBI
|
|
35
|
Reinfuss M, Mituś J, Smolak K and Stelmach
A: Malignant phyllodes tumours of the breast. A clinical and
pathological analysis of 55 cases. Eur J Cancer. 29A:1252–1256.
1993. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Chaney AW, Pollack A, McNeese MD and
Zagars GK: Adjuvant radiotherapy for phyllodes tumor of breast.
Radiat Oncol Investig. 6:264–267. 1998. View Article : Google Scholar : PubMed/NCBI
|
